Nootropic

    CMS 121

    A novel neuroprotective compound that targets fatty acid synthase (FASN) to reduce lipid peroxidation and protect against age-related cognitive decline.

    Common Dosage

    Research phase (preclinical)

    Category

    Nootropic

    Known Benefits
    • Neuroprotection
    • Anti-aging for brain
    • Cognitive preservation
    • Lipid peroxidation reduction
    History & Background

    CMS 121 was developed by the Bhanu Bharat group at the Salk Institute as part of a research program identifying compounds that protect against age-related neurodegeneration. It is a derivative of fisetin (a natural polyphenol) engineered for improved neuroprotective potency. The compound targets fatty acid synthase (FASN) as part of its mechanism, reducing toxic lipid accumulation in aging neurons. It represents an example of precision medicinal chemistry applied to cognitive aging.

    How It Works

    CMS 121 inhibits fatty acid synthase (FASN) in neurons, reducing the accumulation of lipid peroxidation byproducts that increase with aging and oxidative stress. Lipid peroxidation in neuronal membranes is a major contributor to age-related synaptic dysfunction and neurodegeneration. By reducing this process, CMS 121 preserves mitochondrial function and synaptic integrity. It also modulates the mTOR pathway toward autophagy — cellular cleanup processes that decline with age.

    Research & Clinical Applications
    • Age-related cognitive decline prevention
    • Alzheimer's disease preclinical research
    • Lipid peroxidation reduction in neural tissue
    • Neuroprotection following oxidative stress
    Notable Research Outcomes

    Aged Mouse Cognitive Rescue

    CMS 121-treated aged mice showed significant improvements in memory and learning tests, associated with reduced markers of lipid peroxidation and improved mitochondrial function in hippocampal tissue. The effect was comparable to caloric restriction in some parameters.

    Known Concerns & Considerations
    • Entirely preclinical — no human data whatsoever
    • FASN inhibition has broad metabolic implications beyond neurology — cancer metabolism, liver lipid synthesis, and reproductive tissue effects
    • No established dosing, safety profile, or optimal delivery route for humans
    • Research-grade versions are not characterized
    Reported Side Effects
    • Unknown (Research compound)
    Available From
    Dosage Calculator

    Use our visual calculator to work out exact dosages and insulin unit conversions for CMS 121.

    Reconstitution Guide

    Step-by-step instructions for safely reconstituting peptides with BAC water.

    Research Use Only. The information on this page is intended for educational purposes only. These compounds are not FDA-approved for general use. Consult a qualified medical professional before using any peptide.